phase readout
saveNCT04980495: An Open-label Study to Investigate the Clinical Efficacy of Different Dosing Regimens of Efgartigimod IV in Patients With Generalized Myasthenia Gravis
COMPLETEDupdated 1mo ago
community read0 votes
Sponsor: argenx. Phase: PHASE3. Conditions: Generalized Myasthenia Gravis, MG - Myasthenia Gravis, gMG
view source ↗
comments(0)
5-min edit window · permanent after that